Sildenafil
Priapism
Johns Hopkins UniversitySmall moleculePhase 2Dormant
B
56/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 41/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Priapism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Hydroxyurea Vanderbilt University Medical Center | Phase 2 | B |
Crizanlizumab Novartis Pharmaceuticals | Phase 2 | B |
Tadalafil Vanderbilt University Medical Center | Phase 2 | B |
TESTOSTERONE UNDECYLATE Johns Hopkins University | Early Phase 1 | C |
Same molecule, other indications
Sildenafil is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →